Who owns the MY ROMVIMZA trademark?

The MY ROMVIMZA trademark is owned by Deciphera Pharmaceuticals, LLC.

What class is the MY ROMVIMZA trademark registered in?

The MY ROMVIMZA trademark is registered in Class 009 (Electronics, software & scientific instruments).

What is the serial number for MY ROMVIMZA?

The USPTO serial number for MY ROMVIMZA is 99256741.

What is the registration number for MY ROMVIMZA?

MY ROMVIMZA is registered under USPTO registration number 8505029.

MYR

USPTO Trademark Record

REGISTERED

MY ROMVIMZA

SN 99256741·Reg 8505029·Filed Jun 27, 2025

Owner Deciphera Pharmaceuticals, LLC

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable multimedia files, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus.

MY ROMVIMZA (Serial No. 99256741), Registration No. 8505029, is a registered US trademark filed on Jun 27, 2025 by Deciphera Pharmaceuticals, LLC. This trademark covers Class 009 (Electronics, software & scientific instruments).

early section 8: October 13, 2032

Mark Intelligence

MY ROMVIMZA (Reg. #8505029) is a registered US trademark that has been protecting its owner, Deciphera Pharmaceuticals, LLC, since 2025. The mark covers Class 009 (Electronics, software & scientific instruments). Goods and services include Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, s.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 27, 2025

SERIAL

99256741

REG#

8505029

REGISTERED

Oct 13, 2026

Owner

Applicant

Deciphera Pharmaceuticals, LLC

Entity

LLC

State

Address

Building B, 200 Smith Street, Waltham, MA, 02451

Country

Attorney

NameKaren Won

Law firm

Karen Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.

Docket

062902-400

Address

One Financial Center, Boston, MA 02111, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 27, 2025

Serial Number99256741

Registration No.8505029

Registration DateOct 13, 2026

Status DateOct 13, 2026

Published for OppositionDec 23, 2025

Mark TypeDesign with words

Attorney Docket062902-400

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 009Electronics, software & scientific instruments

US codes: 021, 023, 026, 036, 038

First use anywhere: Jun 09, 2025

First use in commerce: Jun 09, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

REGISTERED-PRINCIPAL REGISTER

Oct 13, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 13, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 22, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 22, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jul 29, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

May 27, 2026

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

May 27, 2026

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 17, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 23, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 23, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 17, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Nov 25, 2025

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Nov 25, 2025

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 25, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Nov 25, 2025

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 25, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 17, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 06, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 06, 2025

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Jun 27, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Jun 27, 2025

APPLICATION FILING RECEIPT MAILED

MY ROMVIMZA

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Deciphera Pharmaceuticals, LLC

Other Marks in Class 009 — Electronics, software & scientific instruments

Other Marks by Karen Won

Resources

Company